Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
28
29
30
1
3
4
5
6
7
8
9
10
11
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
American Academy of Pediatrics Virtual National Conference & Exhibition
2020-10-02 - 2020-10-05    
12:00 am
Organized by the American Academy of Pediatrics Experience education wherever you are, whenever you’d like with over 150 on-demand sessions and more than 35 live [...]
16th World Congress on Public Health 2020
2020-10-12 - 2020-10-16    
12:00 am
Organized by Multiple Partners or Sponsors The global public health community will be meeting at a critical time for our planet. Global temperatures lie far [...]
BARDA Industry Day
2020-10-27    
12:00 am
Organized by BARDA BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities, interact with BARDA [...]
Events on 2020-10-12
Events on 2020-10-27
BARDA Industry Day
27 Oct 20
Latest News

Trial tests EHR alerts in seniors

Northwestern Medicine researchers achieved notable reductions in unnecessary testing using EHR alerts. The study demonstrated substantial decreases in unnecessary prostate-specific antigen testing, urine testing, and prescription of hypoglycemic agents. EHR alerts resulted in an 8.7% decrease in PSA testing, a 5.5% reduction in urine testing, and a 1.4% decline in overtreating blood sugar. The study’s focus on potential harms, social norms, and social accountability contributed to designing effective alerts. This contrasts with limited success in changing clinician behavior through other research. Lead author Stephen Persell underscores the importance of incorporating these elements for effective alerts.

Examining older men for prostate cancer may not significantly prolong their lives, but it may expose them to potential harms from unnecessary treatments like surgery or radiation. These treatments could lead to issues such as urinary problems, sexual dysfunction, or rectal bleeding. A parallel risk exists when testing women for urinary tract infections and treating older adults with diabetes using blood glucose-lowering drugs, potentially resulting in dangerous outcomes.